Rosiglitazone improves insulin sensitivity by increasing plasma adiponectin and decreasing plasma resistin, and by reducing abdominal visceral adipose tissue in type 2 diabetic patients

被引：0
|
作者：
Cho, MH
Nam, JY
Song, YD
Kim, HJ
Kim, CS
Ahn, CW
Cha, BS
Yoo, JM
Lim, SK
Kim, KR
Lee, HC
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A527 / A527
页数：1
相关论文
共 50 条
  • [41] Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients
    Lihn, AS
    Ostergård, T
    Nyholm, B
    Pedersen, SB
    Richelsen, B
    Schmitz, O
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2003, 284 (02): : E443 - E448
  • [42] CAIAPO® improves insulin sensitivity and glucose tolerance in type-2 diabetic patients
    Ludvik, B
    Mahdjoobian, K
    Hofer, A
    Kautzky-Willer, A
    Prager, R
    Waldhaeusl, W
    Pacini, G
    DIABETES, 2000, 49 : A115 - A115
  • [43] Correlation of Computed Tomography Guided Visceral Adiposity & Sagittal Abdominal Diameter with Atherogenic Index of Plasma in Type 2 Diabetic Patients
    Rao, Pradyumna
    Bindu, Chavala Mohan
    Ramachary, Usha Setty Muthihar
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2021, 10 (16): : 1145 - 1149
  • [44] Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia
    Otto, C.
    Otto, B.
    Frost, R. J. A.
    Vogeser, M.
    Pfeiffer, A. F. H.
    Spranger, J.
    Parhofer, K. G.
    ACTA DIABETOLOGICA, 2007, 44 (02) : 65 - 68
  • [45] Supplementation of α-linolenic acid improves serum adiponectin levels and insulin sensitivity in patients with type 2 diabetes
    Gomes, Patricia M.
    Hollanda-Miranda, Wallace R.
    Beraldo, Rebeca A.
    Castro, Ana V. B.
    Geloneze, Bruno
    Foss, Milton C.
    Foss-Freitas, Maria C.
    NUTRITION, 2015, 31 (06) : 853 - 857
  • [46] Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia
    C. Otto
    B. Otto
    R. J. A. Frost
    M. Vogeser
    A. F. H. Pfeiffer
    J. Spranger
    K. G. Parhofer
    Acta Diabetologica, 2007, 44 : 65 - 68
  • [47] Plasma Adiponectin Levels Are Markedly Elevated in Imatinib-Treated Chronic Myeloid Leukemia (CML) Patients: A Mechanism for Improved Insulin Sensitivity in Type 2 Diabetic CML Patients?
    Fitter, Stephen
    Vandyke, Kate
    Schultz, Christopher G.
    White, Deborah
    Hughes, Timothy P.
    Zannettino, Andrew C. W.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (08): : 3763 - 3767
  • [48] The combination of insulin resistance and visceral adipose tissue estimation improves the performance of metabolic syndrome as a predictor of type 2 diabetes
    Antonio-Villa, N. E.
    Bello-Chavolla, O. Y.
    Vargas-Vazquez, A.
    Mehta, R.
    Aguilar-Salinas, C. A.
    DIABETIC MEDICINE, 2020, 37 (07) : 1192 - 1201
  • [49] Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokine in type 2 diabetic patients
    Miyazaki, Yoshinori
    Defronzo, Ralph A.
    DIABETES, 2008, 57 : A587 - A587
  • [50] Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients
    Miyazaki, Y.
    DeFronzo, R. A.
    DIABETES OBESITY & METABOLISM, 2008, 10 (12): : 1204 - 1211
12345